Loading clinical trials...

The Course of Hip Flexion Weakness Following LLIF or ALIF | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

The Course of Hip Flexion Weakness Following LLIF or ALIF

NCT04204135•Rush University Medical Center

Summary

The purpose of this study is to assess the course of hip weakness after LLIF or ALIF procedures. These outcomes include measures of hip strength using a dynamometer, which is a device used to measure muscle strength. While it is known that people experience temporary hip and leg weakness after an LLIF or ALIF, the exact timing of when hip and leg strength is regained after an LLIF or ALIF is not known.

Eligibility

Age

0 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1-, 2-, or 3-level L2L3, L3L4, or L4L5 LLIF or ALIF for degenerative pathology including radiculopathy, neurogenic claudication, intervertebral disc disease, facet joint disease, degenerative spondylolisthesis, degenerative myelopathy degenerative kyphosis, and scoliosis
•Back and/or leg pain
•Failed at least 6 months of conservative treatment

Exclusion Criteria

•Older than 65 years of age
•Prior spinal fusion surgery
•Greater than Grade 2 spondylolisthesis
•Greater than 10° scoliosis
•History of spinal infection

Locations (1)

Rush University Medical Center

Chicago, Illinois, United States

Key Dates

Start Date

October 4, 2018

Primary Completion Date

September 4, 2027

Completion Date

November 4, 2027

Last Updated

September 24, 2025

Enrollment

ESTIMATED participants

Conditions

Degenerative Disc DiseaseHerniated Nucleus PulposusSpondylolisthesis

Interventions

LLIF or ALIF procedures

PROCEDURE

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

NCT07254806

Degenerative Disc Disease

View study

RECRUITINGNA

"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)

NCT05508360

Degenerative Disc DiseaseChronic Low-back Pain

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Course of Hip Flexion Weakness Following LLIF or ALIF

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

Real World Data Collection on the Synergy Disc